ATH Price sensitive 7 Jul 2026, 9:44 AM

FDA Meeting Minutes Confirm Registrational Path for ATH434

Alterity Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in